Navigation Links
Pharmaxis Investor Conference Call
Date:1/26/2009

SYDNEY, Australia, Jan. 27 /PRNewswire-Asia/ -- Pharmaxis Ltd (AXS: PXS, Nasdaq: PXSL) will release its December 2008 Quarterly Report to Shareholders on the afternoon of Wednesday, 28th January 2009. Dr. Alan Robertson will host an investor teleconference the following morning to review the quarter and answer investor questions.

The teleconference will be on Thursday, 29th January at 8:30am (Sydney), (Wednesday, 28th January at 4:30pm U.S. East Coast, 1:30pm U.S. West Coast).

    Telephone access (toll free) details are below:
    -- Australia: 1800 131 617
    -- USA/Canada:  866 746 2596
    -- UK: 0800 376 8339
    -- NZ: 0800 446 958
    -- Switzerland: 0800 001 230
    -- Online (global access):
      http://services.choruscall.com/links/pharmaxis090129.html

A recording of the conference will be available on the Pharmaxis website home page approximately 3 hours after the call.


    CONTACT: Pharmaxis Investor Relations
    T: +61 2 9454 7200, F +61 2 9451 3622
    E: Investor.Relations@Pharmaxis.com.au
       Website: www.pharmaxis.com.au


'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharmaxis Aridol Approved for Sale in Switzerland
2. Pharmaxis Investor Conference Call
3. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
4. New Pharmaxis Board Appointment
5. Pharmaxis Aridol Authorised for Sale in Germany
6. Pharmaxis First Steps into China
7. Pharmaxis to Apply to Market Bronchitol in Australia
8. Pharmaxis Investor Conference Call
9. Pharmaxis Aridol Gains First Asian Approval
10. Pharmaxis Appoints Portuguese Distributor for Aridol
11. Pharmaxis Closes Share Purchase Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
(Date:6/22/2016)... --  ViaCyte, Inc. , a privately-held regenerative medicine company ... for the treatment of diabetes in clinical-stage development, today ... 2016, the Global Stem Cell Event, is taking place ... Francisco.    ... Focus Session: Tools for Basic and Applied Stem Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
Breaking Biology News(10 mins):